Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation
Abjal Pasha Shaik, Asma Sultana Shaik, Ali Al Majwal, Achraf Al Faraj
Cancer Res Treat. 2017;49(2):322-329.   Published online 2016 Jul 12     DOI:
Citations to this article as recorded by Crossref logo
Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
Kyoung Min Kim, Usama Khamis Hussein, See-Hyoung Park, Young Jae Moon, Zhongkai Zhang, Asmaa Gamal Ahmed, Ae-Ri Ahn, Ho Sung Park, Jung Ryul Kim, Kyu Yun Jang
Diagnostic Pathology.2021;[Epub]     CrossRef
Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering
Mahboubeh Nabavinia, Juan Beltran-Huarac
ACS Applied Bio Materials.2020; 3(12): 8172.     CrossRef
Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways
Mi-Ae Kang, Jongsung Lee, Sang Ha, Chang Lee, Kyoung Kim, Kyu Jang, See-Hyoung Park
Cancers.2019; 11(9): 1394.     CrossRef
Targeted Nanoparticle Binding to Hydroxyapatite in a High Serum Environment for Early Detection of Heart Disease
Cari L. Meisel, Polly Bainbridge, Dimitrios Mitsouras, Joyce Y. Wong
ACS Applied Nano Materials.2018; 1(9): 4927.     CrossRef
Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects
Adil M. Allahverdiyev, Etkin Parlar, Sahar Dinparvar, Melahat Bagirova, Emrah Şefik Abamor
Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): S755.     CrossRef
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
Jörgen Elgqvist
International Journal of Molecular Sciences.2017; 18(5): 1102.     CrossRef